AFT is a growing multinational pharmaceutical company that develops, markets and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major pharmaceutical distribution channels: over-the-counter, prescription and hospital. AFT's product portfolio comprises both proprietary and in-licensed products, and includes patented, branded and generic drugs.
Title | Date | Type |
---|---|---|
Disclosure of Directors and Senior Managers Relevant Intere | Mon, Dec 02 2024 02:45 pm | SHINTR |
Disclosure of Directors and Senior Managers Relevant Int | Wed, Nov 27 2024 04:37 pm | SHINTR |
Disclosure of Directors and Senior Managers Relevant Int | Wed, Nov 27 2024 04:37 pm | SHINTR |
AFT reports record sales and invests for growth | Thu, Nov 21 2024 08:46 am | HALFYR |
AFT appoints Allison Yorston as independent director | Wed, Nov 13 2024 08:30 am | ADMIN |
SPH Notice - Accident Compensation Corporation (ACC) | Thu, Nov 07 2024 03:52 pm | SHINTR |
AFT trading update | Fri, Nov 01 2024 08:40 am | GENERAL |
AFT enters late-stage R&D agreement for a novel injectable | Mon, Oct 21 2024 08:37 am | GENERAL |
Interim results announcement Thurs Nov 21 2024 | Fri, Oct 11 2024 05:08 pm | GENERAL |
AFT Licenses Maxigesic IV in China and USA update | Mon, Sep 30 2024 08:30 am | GENERAL |
Date | Name | No. Held | % | Current |
---|---|---|---|---|
16/09/20 | Forsyth Barr Group Limited and Fors | 1,617,818 | 71.25 | 1.55 |
15/06/20 | Hartley Campbell Atkinson and Colin | 72,031,609 | 72.60 | 69.82 |
15/06/20 | The CRG Persons | - | 15.99 | - |
25/05/17 | AFT Pharmaceuticals Limited | - | 72.34 | - |
Date | Name | No. Held | % | Details | Other |
---|---|---|---|---|---|
18/09/23 | Jon Lamb | 271,314 | - | - | - |
14/04/21 | Malcolm Tubby | 143,892 | - | - | - |
10/08/20 | Hartley Atkinson | 72,899,435 | - | - | - |
03/07/20 | David Flacks | 178,764 | - | - | - |
22/08/18 | James Burns | 125,417 | - | - | - |
19/06/17 | John Douglas Wilson | 56,689 | - | - | - |
profit2021 | profit2022 | eps2021 | dps2021 | sales2021 | ebit2021 | ebitda2021 | |
---|---|---|---|---|---|---|---|
mean | 13.7 | 13.1 | 2.0 | 191.3 | 22.0 | 24.6 | |
high | 13.7 | 13.1 | 2.0 | 191.3 | 22.0 | 24.6 | |
low | 13.7 | 13.1 | 2.0 | 191.3 | 22.0 | 24.6 | |
sample | 1 | 0 | 1 | 1 | 1 | 1 | 1 |